| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), CELU's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.00M | - | - | |
| 10% | 1.46M | - | - | |
| 10% | 1.46M | - | - | |
| ? | 520.0K | - | - | |
| ? | 394.1K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Lim Kok Thay | - | Buy | 21,410,983 | $0.25 | $5,331,334.77 | +71.2% | +113.9% | -0.6% | |
| Oct 5, 2023 | Sorrento Therapeutics, Inc.45 | 10% Owner | Sell | 15,371,697 | $0.00 | - | -75.3% | +33.0% | +25.7% | |
| Oct 5, 2023 | Hariri Robert J60 | Chief Executive Officer | Buy | 18,422,124 | $0.16 | $2,984,294.19 | +181.5% | +33.0% | +25.7% | |
| Nov 30, 2022 | Hariri Robert J60 | Chief Executive Officer | Buy | 10,000 | $1.72 | $17,175.00 | +0.1% | -59.9% | -87.5% | |
| Nov 29, 2022 | Hariri Robert J60 | Chief Executive Officer | Buy | 40,000 | $1.71 | $68,400.00 | +0.5% | -60.1% | -87.4% | |
| Nov 28, 2022 | Hariri Robert J60 | Chief Executive Officer | Buy | 40,000 | $1.74 | $69,600.00 | +0.5% | -59.1% | -86.1% |